Dave serves as Head of Life Science Investment Banking. His extensive industry and Capital Markets experience provide a unique perspective to our Lake Street clients. Dave most recently served as a Senior Financial and Business Development Executive for SillaJen Biotherapeutics, Delcath Systems and AngioDynamics where he raised almost $200 million in capital and successfully negotiated a number of global partnerships and acquisitions. In addition, he has more than 25 years of Capital Markets experience serving the needs of emerging growth companies as a Healthcare Investment Banker, Equity Research Analyst, and Investor with RBC Capital Markets, Craig-Hallum, Canaccord Genuity and American Express. Dave received his BA in Economics from St. Olaf College.